United Therapeutics Corporation
UTHR
$515.46
-$12.45-2.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.92% | -1.62% | 7.38% | 6.76% | 11.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.92% | -1.62% | 7.38% | 6.76% | 11.71% |
| Cost of Revenue | 13.58% | 44.22% | 36.23% | 21.42% | 12.60% |
| Gross Profit | -3.83% | -7.66% | 4.06% | 4.93% | 11.60% |
| SG&A Expenses | 8.33% | 8.23% | 19.36% | 17.98% | 7.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.72% | 10.71% | 17.35% | 20.40% | 4.41% |
| Operating Income | -14.34% | -14.89% | -2.64% | -4.63% | 20.73% |
| Income Before Tax | -8.74% | -24.84% | 11.98% | 12.71% | 14.95% |
| Income Tax Expenses | -59.86% | -57.16% | -16.28% | 24.91% | 28.11% |
| Earnings from Continuing Operations | 7.59% | -14.68% | 20.91% | 9.58% | 11.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.59% | -14.68% | 20.91% | 9.58% | 11.29% |
| EBIT | -14.34% | -14.89% | -2.64% | -4.63% | 20.73% |
| EBITDA | -12.84% | -13.46% | -1.71% | -3.77% | 20.29% |
| EPS Basic | 13.91% | -11.93% | 24.82% | 11.58% | 9.56% |
| Normalized Basic EPS | -12.37% | -8.55% | 2.13% | -2.15% | 20.42% |
| EPS Diluted | 13.42% | -12.22% | 24.54% | 12.05% | 9.57% |
| Normalized Diluted EPS | -12.71% | -8.78% | 1.86% | -1.67% | 20.29% |
| Average Basic Shares Outstanding | -5.54% | -3.12% | -3.13% | -1.79% | 1.58% |
| Average Diluted Shares Outstanding | -5.18% | -2.88% | -2.87% | -2.27% | 1.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |